Congressional Record, Volume 168 Issue 186 (Thursday, December 1, 2022)

[Congressional Record Volume 168, Number 186 (Thursday, December 1, 2022)]
[Senate]
[Pages S6946-S6947]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

CARDIOVASCULAR ADVANCES IN RESEARCH AND OPPORTUNITIES LEGACY ACT

Mr. KING. Madam President, I ask unanimous consent that the Senate
proceed to the immediate consideration of Calendar No. 443, H.R. 1193.
The ACTING PRESIDENT pro tempore. The clerk will report the bill by
title.
The senior assistant legislative clerk read as follows:

A bill (H.R. 1193) to amend title IV of the Public Health
Service Act to direct the Director of the National Institutes
of Health, in consultation with the Director of the National
Heart, Lung, and Blood Institute, to establish a program
under which the Director of the National Institutes of Health
shall support or conduct research on valvular heart disease,
and for other purposes.

There being no objection, the Senate proceeded to consider the bill,
which had been reported from the Committee on Health, Education, Labor,
and Pensions, with an amendment to strike all after the enacting clause
and insert in lieu thereof the following:

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Cardiovascular Advances in
Research and Opportunities Legacy Act''.

SEC. 2. HHS VALVULAR HEART DISEASE ACTIVITIES.

[[Page S6947]]

(3) Mitral valve prolapse workshop.--Not later than one
year after the date of enactment of this Act, the Director of
the National Heart, Lung, and Blood Institute shall, as
appropriate, convene a workshop composed of subject matter
experts and stakeholders to identify research needs and
opportunities to develop recommendations for the
identification and treatment of individuals with mitral valve
prolapse, including such individuals who may be at risk for
sudden cardiac arrest or sudden cardiac death.
(c) Prevention Activities to Improve Awareness of Sudden
Cardiac Death as a Result of Valvular Heart Diseases.--
(1) In general.--The Secretary may carry out activities to
increase education and awareness of valvular heart diseases
in order to reduce the incidence of sudden cardiac death
caused by such diseases. The Secretary may--
(A) award grants or contracts to public or nonprofit
private entities to carry out activities under this
subsection; and
(B) may directly, or through grants or contracts, provide
technical assistance with respect to such activities.
(2) Certain activities.--Upon availability of applicable
data, projects carried out under paragraph (1) may include--
(A) continuing activities at the Centers for Disease
Control and Prevention related to valvular heart diseases;
(B) improving the awareness of the public concerning any
risk factors for, the symptoms of, and the public health
impact of, valvular heart diseases; and
(C) improving the availability of public health data and
information, as appropriate, regarding cardiac arrests
related to valvular heart diseases.
(3) Grant prioritization.--The Secretary may, in awarding
grants or entering into contracts pursuant to paragraph (1),
give priority to entities seeking to carry out projects for
populations most impacted by valvular heart diseases.
(4) Coordination of activities.--The Secretary shall, as
appropriate, ensure that activities under this section are
coordinated with other agencies and offices of the Department
of Health and Human Services that carry out activities
regarding valvular heart diseases.
(5) Best practices.--The Secretary shall, as applicable and
appropriate, identify and disseminate best practices for
relevant health care providers related to valvular heart
diseases.
(d) Authorization of Appropriations.--For purposes of
carrying out this section, there are authorized to be
appropriated such sums as may be necessary for each of fiscal
years 2023 through 2027.
Mr. KING. Madam President, I ask unanimous consent that the
committee-reported substitute amendment be withdrawn; that the
McConnell substitute amendment at the desk be agreed to; that the bill,
as amended, be considered read a third time and passed; and that the
motion to reconsider be considered made and laid upon the table.
The ACTING PRESIDENT pro tempore. Without objection, it is so
ordered.
The committee-reported amendment in the nature of a substitute was
withdrawn.
The amendment (No. 6504) in the nature of a substitute was agreed to,
as follows:
Strike all after the enacting clause and insert the
following:

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Cardiovascular Advances in
Research and Opportunities Legacy Act''.

SEC. 2. HHS VALVULAR HEART DISEASE ACTIVITIES.

(a) In General.--The Secretary of Health and Human Services
(referred to in this section as the ``Secretary'') shall, as
appropriate, continue activities related to research,
education, and awareness of valvular heart diseases.
(b) NIH Research Related to Valvular Heart Diseases.--
(1) In general.--The Director of the National Institutes of
Health, in consultation with the Director of the National
Heart, Lung, and Blood Institute, may support or conduct
research regarding valvular heart diseases.
(2) Support further research.--In order to improve
information on, and understanding of, causation and risk
factors for valvular heart diseases, research conducted or
supported under this subsection for such diseases may include
the following:
(A) Use of advanced technological imaging and other
relevant methods to generate data related to valvular heart
diseases.
(B) Assessing potential risk factors for sudden cardiac
arrest or sudden cardiac death from valvular heart diseases.
(C) Other activities, as appropriate, in order to improve
the availability of information on, and advance research
related to, valvular heart diseases.
(3) Mitral valve prolapse workshop.--Not later than 2 years
after the date of enactment of this Act, the Director of the
National Heart, Lung, and Blood Institute shall, as
appropriate, convene a workshop composed of subject matter
experts and stakeholders to identify research needs and
opportunities to develop recommendations for the
identification and treatment of individuals with mitral valve
prolapse, including such individuals who may be at risk for
sudden cardiac arrest or sudden cardiac death.
(c) Prevention Activities to Improve Awareness of Sudden
Cardiac Death as a Result of Valvular Heart Diseases.--
(1) In general.--The Secretary may carry out activities to
increase education and awareness of valvular heart diseases
in order to reduce the incidence of sudden cardiac death
caused by such diseases. The Secretary may--
(A) award grants or contracts to public or nonprofit
private entities to carry out activities under this
subsection; and
(B) directly, or through grants or contracts, provide
technical assistance with respect to such activities.
(2) Certain activities.--Upon availability of applicable
data, projects carried out under paragraph (1) may include--
(A) continuing activities at the Centers for Disease
Control and Prevention related to valvular heart diseases;
(B) improving the awareness of the public concerning any
risk factors for, the symptoms of, and the public health
impact of, valvular heart diseases; and
(C) enhancing public health data collection and improving
the quality of such data, as appropriate, regarding cardiac
arrests, including cardiac arrests that occur outside of the
hospital.
(3) Grant prioritization.--The Secretary may, in awarding
grants or entering into contracts pursuant to paragraph (1),
give priority to entities seeking to carry out projects for
populations most impacted by valvular heart diseases.
(4) Coordination of activities.--The Secretary shall, as
appropriate, ensure that activities under this section are
coordinated with other agencies and offices of the Department
of Health and Human Services that carry out activities
regarding valvular heart diseases.
(5) Best practices.--The Secretary shall, as applicable and
appropriate, identify and disseminate best practices for
relevant health care providers related to valvular heart
diseases.
(d) Authorization of Appropriations.--For purposes of
carrying out this section, there are authorized to be
appropriated $28,000,000 for each of fiscal years 2023
through 2027.
The amendment was ordered to be engrossed and the bill to be read a
third time.
The bill was read the third time.
The bill (H.R. 1193), as amended, was passed.

____________________